Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-04-01
1997-06-10
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514568, A61K 3119
Patent
active
056376170
ABSTRACT:
A method is disclosed for potentiating mammalian GABA.sub.A receptor responses to GABA. The receptor responses are potentiated according to the invention by contacting GABA.sub.A receptors with GABA and an effective amount of non-steroidal anti-inflammatory agents, in particular, fenamates and structurally related compounds.
REFERENCES:
Picrate and Niflumate Block Anion Modulation of Radioligand Binding to the .beta.-Aminobutyric Acid/Benzodiazepine Receptor Complex Evoniuk and Skolnick, Molecular Pharmacology, 34:837-842, 1988.
Chloride Transport Blockers Prevent N-Methyl-D-aspartate Receptor-Channel Complex Activation Lerma and Del Rio, Molecular Pharmacology, 41:217-222, 1991.
Actions of Pentobarbital on Rat Brain Receptors Expressed in Xenopus Oocytes Parker, The Journal of Neuroscience, No. 6, 8:2290-2297, Aug. 1986.
Inhibition of Anion Permeability by Amphiphilic Compounds in Human Red Cell: Evidence for an Interaction of Niflumic Acid with the Band 3 Protein Cousin and Motais, J. Membrane Biol., 46:125-153, 1979.
Gastritis, Duodenitis, and Bleeding Duodenal Ulcer Following Mefenamic Acid Therapy Wolfe, et al., Arch. Intern Med., 136:923-925, Aug. 1976.
The Actions of the Non-Steroidal Anti-Inflammatory Drug, Metenamic Acid with the GABA.sub.A Receptor Halliwell et al., Br. J. Pharmacol., 96:139P, 1989.
Non-competitive inhibition of GABA.sub.A responses by a new class of quinolones and non-steroidal anti-inflammatories in dissociated frog sensory neurones Yakushiji, et al., Br. J. Pharmacol., 105:13-18, 1992.
Interaction of various non-steroidal anti-inflammatories and quinolone antimicrobials on GABA response in rat dissociated hippocampal pyramidal neurons Shirasaki, et al., Brain Research, 562:329-331, 1991.
Inhibition of GABA.sub.A Receptor-Mediated Current Responses By Enoxacin (New Quinolone) and Felbinac (Non-Steroidal Anti-Inflammatory Drug) In . . . Kawakami, et al., Biol. Pharm. Bull., No. 7, 16:726-728, 1993.
Responses to GABA, glycine and .beta.-alanine induced in Xenopus oocytes by messenger RNA from chick and rat brain Parker, et al., Proc. R. Soc. Lond. B., 233:201-216, 1988.
Activation of protein kinase C differentially modulates neuronal Na.sup.+, Ca.sup.2+, and .beta.aminobutyrate type A channels Sigel and Baur, Proc. Natl. Acad. Sci. USA, 85:6192-6196, Aug. 1988.
Effects of Fenamates and Other Nonsteroidal Anti-inflammatory Drugs on Rat Brain GABA.sub.A Receptors Expressed in Xenopus Oocytes Woodward, et al., The Jrnl. of Pharm. and Exp. Ther., 268:806-817, 1994.
Miledi Ricardo
Woodward Richard M.
Spivack Phyllis G.
The Regents of the University of California
LandOfFree
Methods for use of GABA.sub.a receptor GABAergic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for use of GABA.sub.a receptor GABAergic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for use of GABA.sub.a receptor GABAergic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764932